Open AccessMolecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer
Author(s) -
Keishiro Aoyagi,
Kikuo Kouhuji,
Motoshi Miyagi,
Junya Kizaki,
Taro Isobe,
K Hashimoto,
Kazuo Shirouzu
Publication year - 2013
Publication title -
world journal of critical care medicine
Language(s) - English
Resource type - Journals
ISSN - 2220-3141
DOI - 10.5492/wjccm.v2.i4.48
Subject(s) - medicine , bevacizumab , metastasis , vascular endothelial growth factor , cancer , cancer research , cancer cell , matrix metalloproteinase , targeted therapy , peritoneum , ascites , oncology , pathology , immunology , chemotherapy , vegf receptors
To clarify the significance of vascular endothelial growth factor (VEGF) in peritoneal metastasis from gastric cancer, using the gastric cancer cell line MKN-45 compared with the high potential peritoneal dissemination gastric cancer cell line MKN-45P.